학술논문
1281O Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB+) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C
Document Type
Abstract
Author
Source
In Annals of Oncology September 2021 32 Supplement 5:S950-S951
Subject
Language
ISSN
0923-7534